Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery
- 1 June 1993
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 12 (6) , 449-453
- https://doi.org/10.1007/bf01967440
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.1991
- Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy malesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In-vitro activity of meropenem, a new carbapenem, against multiresistant Pseudomonas aeruginosa compared with that of other antipsendomonal antimicrobialsJournal of Antimicrobial Chemotherapy, 1989
- Susceptibility of anaerobic bacteria to meropenemJournal of Antimicrobial Chemotherapy, 1989
- Meropenem: evidence of lack of proconvulsive tendency in miceJournal of Antimicrobial Chemotherapy, 1989
- Comparative toxicities of third-generation cephalosporinsThe American Journal of Medicine, 1985
- Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infectionsThe American Journal of Medicine, 1985
- Imipenem/cilastatin in the treatment of obstetric and gynecologic infectionsThe American Journal of Medicine, 1985
- Imipenem/cilastatin versus gentamicin/clindamycin for treatment of serious bacterial infections. Report from a Scandinavian Study Group.1984
- Moxalactam in Serious Infections: Clinical, Bacteriologic, and Pharmacokinetic StudiesClinical Infectious Diseases, 1982